Beijing Strong Biotechnologies,Inc. (SHE:300406)
China
· Delayed Price · Currency is CNY 12.41
+0.10 (0.81%)
Apr 29, 2026, 1:45 PM CST
SHE:300406 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,371 | 1,356 | 1,648 | 1,737 | 1,508 | 1,598 | Upgrade
|
| Other Revenue | - | - | 11.28 | 4.4 | 2.88 | 1 | Upgrade
|
| Revenue | 1,371 | 1,356 | 1,659 | 1,742 | 1,511 | 1,599 | Upgrade
|
| Revenue Growth (YoY) | -13.52% | -18.29% | -4.75% | 15.27% | -5.53% | 88.58% | Upgrade
|
| Cost of Revenue | 279.12 | 279.92 | 361.88 | 445.01 | 384.12 | 448.5 | Upgrade
|
| Gross Profit | 1,091 | 1,076 | 1,297 | 1,297 | 1,127 | 1,151 | Upgrade
|
| Selling, General & Admin | 405.35 | 408.88 | 457.67 | 491.04 | 457.36 | 444.38 | Upgrade
|
| Research & Development | 179.28 | 181.73 | 188.53 | 162.9 | 137.2 | 127.01 | Upgrade
|
| Other Operating Expenses | 9.61 | 10.19 | 15.45 | 14.97 | 12.85 | 12.92 | Upgrade
|
| Operating Expenses | 594.23 | 600.81 | 665.03 | 692.35 | 625.46 | 602.71 | Upgrade
|
| Operating Income | 497.16 | 474.78 | 632.01 | 604.27 | 501.29 | 548.17 | Upgrade
|
| Interest Expense | - | - | -47.61 | -46.99 | -52.64 | -21.59 | Upgrade
|
| Interest & Investment Income | 15.8 | 12.14 | 19.82 | 25.95 | 21.48 | 15.74 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0.1 | -0.12 | 2.21 | -0.29 | Upgrade
|
| Other Non Operating Income (Expenses) | -67.94 | -67.03 | 2.39 | -3.5 | -28.33 | -19.94 | Upgrade
|
| EBT Excluding Unusual Items | 445.01 | 419.88 | 606.52 | 579.62 | 444.01 | 522.09 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -3.03 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.15 | - | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.2 | -2.87 | -2.11 | -3.5 | -2.68 | 0.16 | Upgrade
|
| Asset Writedown | -180.76 | -180.76 | -1.38 | -0.21 | -2.29 | -0.11 | Upgrade
|
| Other Unusual Items | - | - | 17.66 | 17.64 | 13.35 | 14.85 | Upgrade
|
| Pretax Income | 262.21 | 236.25 | 620.69 | 593.55 | 449.35 | 536.99 | Upgrade
|
| Income Tax Expense | 49.64 | 45.71 | 89.53 | 71.48 | 54.89 | 67.33 | Upgrade
|
| Earnings From Continuing Operations | 212.58 | 190.54 | 531.16 | 522.07 | 394.46 | 469.66 | Upgrade
|
| Minority Interest in Earnings | -0.35 | -0.66 | 1.47 | 1.67 | -5.37 | -64.01 | Upgrade
|
| Net Income | 212.22 | 189.87 | 532.64 | 523.74 | 389.1 | 405.65 | Upgrade
|
| Net Income to Common | 212.22 | 189.87 | 532.64 | 523.74 | 389.1 | 405.65 | Upgrade
|
| Net Income Growth | -57.63% | -64.35% | 1.70% | 34.60% | -4.08% | 261.30% | Upgrade
|
| Shares Outstanding (Basic) | 591 | 593 | 579 | 582 | 581 | 588 | Upgrade
|
| Shares Outstanding (Diluted) | 591 | 593 | 592 | 595 | 614 | 588 | Upgrade
|
| Shares Change (YoY) | -1.95% | 0.26% | -0.56% | -3.00% | 4.37% | 7.25% | Upgrade
|
| EPS (Basic) | 0.36 | 0.32 | 0.92 | 0.90 | 0.67 | 0.69 | Upgrade
|
| EPS (Diluted) | 0.36 | 0.32 | 0.90 | 0.88 | 0.67 | 0.69 | Upgrade
|
| EPS Growth | -56.79% | -64.44% | 2.27% | 31.47% | -2.99% | 236.88% | Upgrade
|
| Free Cash Flow | 558.46 | 525.87 | 546.36 | 437.06 | 299.69 | 275.9 | Upgrade
|
| Free Cash Flow Per Share | 0.94 | 0.89 | 0.92 | 0.73 | 0.49 | 0.47 | Upgrade
|
| Dividend Per Share | - | - | 0.400 | 0.200 | 0.100 | 0.100 | Upgrade
|
| Dividend Growth | - | - | 100.00% | 100.00% | - | 0.66% | Upgrade
|
| Gross Margin | 79.63% | 79.35% | 78.19% | 74.45% | 74.58% | 71.96% | Upgrade
|
| Operating Margin | 36.27% | 35.03% | 38.10% | 34.70% | 33.18% | 34.27% | Upgrade
|
| Profit Margin | 15.48% | 14.01% | 32.11% | 30.07% | 25.75% | 25.36% | Upgrade
|
| Free Cash Flow Margin | 40.75% | 38.80% | 32.93% | 25.09% | 19.84% | 17.25% | Upgrade
|
| EBITDA | 567.6 | 544.87 | 700.68 | 658.03 | 554.35 | 590.51 | Upgrade
|
| EBITDA Margin | 41.41% | 40.20% | 42.24% | 37.78% | 36.69% | 36.92% | Upgrade
|
| D&A For EBITDA | 70.45 | 70.09 | 68.67 | 53.76 | 53.05 | 42.33 | Upgrade
|
| EBIT | 497.16 | 474.78 | 632.01 | 604.27 | 501.29 | 548.17 | Upgrade
|
| EBIT Margin | 36.27% | 35.03% | 38.10% | 34.70% | 33.18% | 34.27% | Upgrade
|
| Effective Tax Rate | 18.93% | 19.35% | 14.42% | 12.04% | 12.22% | 12.54% | Upgrade
|
| Revenue as Reported | - | - | 1,659 | 1,742 | - | 1,599 | Upgrade
|
| Advertising Expenses | - | - | 153.01 | 194.01 | 200.07 | 186.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.